Picture of Bioventus logo

BVS Bioventus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Bioventus Inc reports results for the quarter ended in September - Earnings Summary

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of 8
cents​​ per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for earnings of
12 cents per share.
    * Revenue fell 79.8% to $22.02 million from a year ago;
analysts
expected $141.59 million. 
    * Bioventus Inc's reported EPS for the quarter was 3 cents​.
    * The mean earnings estimate of analysts had fallen by
about 29.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Bioventus Inc shares had risen by 0.9% this quarter and
lost 51.3% so far this year.
    * The company reported quarterly net income of $3.18
million.
    * Wall Street's median 12-month price target for Bioventus
Inc is
$15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.12           0.08           Missed
 Jun. 30 2022      0.16           0.10           Missed
 Mar. 31 2022      0.05           0.04           Missed
 Dec. 31 2021      0.18           0.26           Beat

Recent news on Bioventus

See all news